CAR NK cells directed toward EGFR or the constitutively activated mutant EGRFvIII GBM tumor antigen (55, 56) and ErbB2 (92) have shown potent cytotoxicity toward primary GBM tumor cells and cell lines in vitro. The gene discussed is EGFR; the disease is neoplasm.